BioNTech SE - ADR vs Invesco DB Commodity Index Tracking Fund — how do they compare? BioNTech SE - ADR trades at $90.4 (market cap $22.78B), while Invesco DB Commodity Index Tracking Fund trades at $28.98. The key difference: Invesco DB Commodity Index Tracking Fund is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | DBC | |
|---|---|---|
Market Cap | $22.78B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $119.34 | $31.69 |
52-Week Low | $83.89 | $21.62 |
Enterprise Value | $6.45B | — |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →DBC is a diversified commodity ETF that tracks the DBIQ Optimum Yield Diversified Commodity Index. It invests in futures contracts for 14 heavily traded commodities, including crude oil, gold, and corn, while optimizing for yield and roll costs.
Read more on DBC →